R. Dellinger

Epidemiology · 2004–2017

A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom R. Dellinger trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. N. Steigbigel
  2. R. Mehta
  3. J. Krinsley

Who trusts R. Dellinger overall

  1. P. Marik
  2. R. Wiener
  3. Mitchell M. Levy

Papers from R. Dellinger's perspective

Ordered by how strongly the researchers R. Dellinger trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care (Critical Care Medicine)
  2. Intensive insulin therapy in the medical ICU. (New England Journal of Medicine)
  3. Hydrocortisone therapy for patients with septic shock. (New England Journal of Medicine)
  4. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock (Critical Care Medicine)
  5. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock (Current Infectious Disease Reports)
  6. Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock
  7. Drotrecogin alfa (activated) in adults with septic shock. (New England Journal of Medicine)
  8. Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients. (Clinical Nutrition)
  9. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. (American Journal of Respiratory and Critical Care Medicine)
  10. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial. (Journal of the American Medical Association (JAMA))

Their papers